leadership

Anthony Mack, a distinguished pharmaceutical and biotech entrepreneur, brings a wealth of experience garnered over his 35-year career. Formerly the President and CEO of Scilex Pharmaceuticals (Nasdaq: SCLX) and the visionary founder of ProSolus Inc., successfully acquired by Mission Pharmacal, his journey underscores a legacy of innovation in the

competitive pharmaceutical and biotech landscape.

Anthony's influential leadership as the CEO of Virpax Pharmaceuticals (Nasdaq: VRPX) showcased a succession of milestones, including securing patents, orchestrating a successful IPO in 2021, raising over $60 million in funding, and obtaining substantial grants from the National Institute of Health and the Department of Defense for three different indications.

Currently serving as the Chief Executive Officer (CEO) at Pathways Neuro Science, Anthony spearheads the development of proprietary solutions targeting addictive behaviors. Employing a cutting-edge gene therapy approach with the Pathways proprietary AAV6.2FF— a significantly improved and safer mutation of AAV6— Pathways’ Adeno Viral Vector drug delivery platform focuses on controlling long-term behaviors associated with alcoholism and opioid addiction. Guided by Anthony's strategic vision, Pathways aims to leverage the latest breakthroughs in brain processes to unlock the neuro-mechanical basis of addiction and obsessive behavior.

Pathways is dedicated to propelling behavioral health forward with groundbreaking therapies. Aligning with Anthony's strategic direction, the company prioritizes the development of innovative solutions. With a focus on precision and efficacy, the Pathways AAV6.2FF Adeno Viral Vector Transgene delivery platform ensures targeted, effective, rapid, and sustainable expression in the brain.

Doug Centilli is an experienced executive with two decades of service at the United States Capitol in Washington DC where he held the positions of Chief of Staff to United States Congressman Kevin Brady and Director of National Econmic Policy for The Joint Economic Committee. He played key roles in healthcare policy including the areas of biotechnology and R&D. Doug is a Member of the Founders' circle of The Texas A&M Institute for Genomic Medicine, a cutting-edge genomic research center that houses the world’s largest library of embryonic mouse stem cells.  Mr. Centilli’s public service began in the Texas Capitol in Austin where he held senior positions for members of the House of Representatives and served as a Special Assistant in the Office of Governor Bill Clements. He serves on the board of the Archer Center at the University of Texas and Sights Unseen, a unique program that provides vision care in developing countries. Doug also serves on the advisory board of Helping a Hero, an organization that provides specially adapted homes and community support for severely injured military personnel. He is a graduate of Texas A&M University, where he was also a member of the Texas A&M football team.